Physician profile
Dean Sheppard
NPI 1649286899
$157,220.57
in general payments reported to CMS, 2019-2025
6 companies · $15K in 2025
The $15K reported for 2025 was more than what 99% of Internal Medicine providers received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $23K · 2021: $28K · 2022: $22K · 2023: $31K · 2024: $39K · 2025: $15K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $83K · Travel and Lodging: $1,099 · Food and Beverage: $385.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $83,160.00 |
| Travel and Lodging | $1,099.24 |
| Food and Beverage | $384.94 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Genentech, INC. | $74,500.00 | 2020-2025 | |
| Genentech USA, INC. | $44,000.00 | 2023-2024 | |
| Amgen INC. | $29,049.24 | 2020-2025 | |
| Abbvie INC. | $5,776.39 | 2020-2024 | |
| Gilead Sciences, INC. | $3,894.94 | 2024-2025 |
1 company reported research payments only; those appear in the research section below.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Dean Sheppard listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.